3‐Nitropropionic acid’s lethal triplet: Cooperative pathways of neurodegeneration

NeuroReport

Volumn 9, Issue 11, 1998, Pages R57-R64

  Alexi, Tajrena ^a   Hughes, Paul E ^a   Faull, Richard L M ^a   Williams, Chris E ^a  

^a Starship Hospital   (New Zealand)

Author keywords

Apoptosis; Basal ganglia; Chorea; Excitotoxicity; Huntington s disease; Malonic acid; Metabolic compromise; Mitochondrial respiration; Oxidative stress; Striatum

Indexed keywords

3 NITROPROPIONIC ACID; 7 NITROINDAZOLE; AMINOGUANIDINE; DIZOCILPINE; LAMOTRIGINE; MALONIC ACID; MEMANTINE; N TERT BUTYL ALPHA (2 SULFOPHENYL)NITRONE; N(G) NITROARGININE METHYL ESTER; NEUROPROTECTIVE AGENT; NEUROTOXIN; NICOTINAMIDE; NITRIC OXIDE SYNTHASE; SUCCINATE DEHYDROGENASE; SUCCINIC ACID; SUPEROXIDE DISMUTASE; TACROLIMUS; UBIDECARENONE; UNCLASSIFIED DRUG;

ANIMAL MODEL; APOPTOSIS; BASAL GANGLION; BRAIN PROTECTION; HUNTINGTON CHOREA; MITOCHONDRIAL RESPIRATION; MOUSE; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; BASAL GANGLIA; CENTRAL NERVOUS SYSTEM; HUMANS; NERVE DEGENERATION; NEUROTOXINS; NITRO COMPOUNDS; PROPIONIC ACIDS;

EID: 0032479940     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/00001756-199808030-00001     Document Type: Review

References (72)

1. Ludolph AC, He F, Spencer PS et al. Can J Neurol Sci 18, 492-498 (1991).
2. Langston W, Ballard P, Tetrud JW et al. Science 219, 979-980 (1983).
3. He F, Zhang S, Qian F et al. Neurology 45, 2178-2183 (1995).
4. Gould DH and Gustine DL. Neuropathol Appl Neurobiol 8, 377-393 (1982).
5. Hamilton BF and Gould DH. Acta Neuropathol 72, 286-297 (1987).
6. Beal MF, Brouillet E, Jenkins B et al. J Neurosci 13, 4181-4192 (1993).
7. Brouillet E, Jenkins BG, Hyman BT et al. J Neurochem 60, 356-359 (1993).
8. Beal MF, Ferrante RJ, Henshaw R et al. J Neurochem 65, 919-922 (1995).
9. Schulz JB, Matthews RT, Jenkins BG et al. J Neurosci 15, 8419-8429 (1995).
10. Brouillet E, Hanatraye P, Ferrante RJ et al. Proc Natl Acad Sci USA 92, 7105-7109 (1995).
11. Palfi S, Ferrante RJ, Brouillet E et al. J Neurosci 16, 3019-3025 (1996).
12. Simpson JR and Isacson O. Exp Neurol 121, 57-64 (1993).
13. Beal MF. Ann Neurol 38, 357-366 (1995).
14. Beal MF, Brouillet E, Jenkins B et al. J Neurochem 61, 1147-1150 (1993).
15. Greene JG, Porter RHP, Eller RV et al. J Neurochem 61, 1151-1154 (1993).
16. Greene JG and Greenamyre JT. J Neurochem 64, 2332-2338 (1995).
17. Greene JG and Greenamyre JT. J Neurochem 64, 430-436 (1995).
18. Greene JG and Greenamyre JT. Bioenergetics and excitotoxicity: the weak excitotoxic hypothesis. In: Olanow CW, Jenner P and Youdim M. eds. Neurodegeneration and Neuroprotection in Parkinson’s Disease. London: Academic Press, 1996: 125-142.
19. Narashima P, Sklar R, Murrell M et al. J Neurosci 15, 7336-7346 (1996).
20. Mello CF de, Begnini J, Jimenez-Bernal RE et al. Brain Res 721, 120-125 (1996).
21. Galpern WR, Matthews RT, Beal MF et al. NeuroReport 7, 2639-2642 (1996).
22. Schulz JB, Huang PL. Matthews RT et al. J Neurochem 67, 430-433 (1996).
23. Deshpande SB, Fukuda A and Nishino H. Exp Neurol 145, 38-45 (1997).
24. Fukuda A, Deshpande SB, Shimano Y et al. Neuroscience, in press (1998).
25. Hassel B and Sonnewald U. J Neurochem 65, 1184-1191 (1995).
26. Behrens MI, Koh J, Canzoniero LMT et al. NeuroReport 6, 545-548 (1995).
27. Pang Z and Geddes JW. J Neurosci 17, 3064-3073 (1997).
28. Greene JG and Greenamyre JT. J Neurochem 66, 637-643 (1996).
29. Erecinska M and Nelson D. J Neurochem 63, 1033-1041 (1994).
30. Dawson R, Beal MF, Bondy SC et al. Toxicol Appl Pharmacol 134, 1-17 (1995).
31. Sokoloff L, Reivich M, Kennedy C et al. J Neurochem 28, 897-916 (1977).
32. Kuroiwa T, Terakado M, Yamaguchi T et al. Neurosci Letts 206, 117-120 (1996).
33. Pang Z, Umberger GH and Geddes JW. J Neurochem 66, 474-484 (1996).
34. Olney JW, Ho OL and Rhee V. Exp Brain Res 14. 61-76 (1971).
35. Cohen G. Adv Neurol 45, 119-125 (1986).
36. Nishino H, Kumazaki M, Fukuda A et al. Neurosci Res 27, 343-355 (1997).
37. McLaughlin BA, Nelson D, Erecinska M et al. J Neurochem, in press (1998).
38. Nishino H, Shimano Y, Kumazaki M et al. Neurosci Letts 186, 161-164 (1995).
39. Novelli A, Reilly JA, Lysko PG et al. Brain Res 451, 205-212 (1988).
40. Zeevalk GD and Nicklas WJ. J Pharmacol Exp Ther 253, 1285-1292 (1990).
41. Bazzett TJ, Falik RC, Becker JB et al. Brain Res 718, 228-232 (1996).
42. Fink SL, Ho DY and Sapolsky RM. Exp Neurol 138, 298-304 (1996).
43. Ludolph AC, Seelig M, Ludolph A et al. Neurodegeneration 1, 155-161 (1992).
44. Riepe M, Hori N, Ludolph AC et al. Brain Res 586, 61-66 (1992).
45. Zeevalk GD, Derr-Yellin E and Nicklas WJ. J Pharmacol Exp Ther 275, 1124-1130 (1995).
46. Blandini F, Porter RH and Greenamyre JT. Mol Neurobiol 12, 73-94 (1996).
47. Albin RL and Greenamyre JT. Neurology 42, 733-738 (1992).
48. Simonian NA and Coyle JT. Annu Rev Pharmacol Toxicol 36, 83-106 (1996).
49. Fu YT, He FS, Zhang SL et al. Toxicon 33, 327-331 (1995).
50. Schulz JB, Henshaw DR, Siwek D et al. J Neurochem 64, 2239-2247 (1995).
51. Nishino H, Fujimoto I, Shimano Y et al. J Chem Neuroanat 10, 209-212 (1996).
52. Schulz JB, Matthews RT, Henshaw R et al. Neuroscience 4, 1043-1048 (1996).
53. Huang N-K, Wan F-J, Tseng C-J et al. NeuroReport 8, 1883-1885 (1997).
54. Beal MF, Henshaw DR, Jenkins BG et al. Ann Neurol 36, 882-889 (1994).
55. Wyllie AH. Nature 284, 555-556 (1980).
56. Clarke PGH. Anat Embryol 181, 195-215 (1990).
57. Kerr JFR and Harmon BV. Definition and incidence of apoptosis: an historical perspective. In: Tomei LD and Cope FO, eds. Apoptosis: The Molecular Basis of Cell Death. New York: Cold Spring Harbor Laboratory Press, 1991: 5-29.
58. Alexi T, Hughes PE, Knusel B et al. Exp Neurol, in press (1998)
59. Sato S, Gobbel GT, Honkaniemi J et al. Brain Res 745, 343-347 (1997).
60. Ankarcrona M, Dypbukt JM, Bonfoco E et al. Neuron 15, 961-973 (1995).
61. Brouillet E and Hantraye P. Curr Opin Neurol 8, 469-473 (1995).
62. Borlongan CV, Koutouzis TK and Sanberg PR. Neurosci Biobehav Rev 21, 289-293 (1997).
63. Wullner U, Young AB, Penney JB et al. J Neurochem 63, 1772-1781 (1994).
64. Bazzett TJ, Falik RC, Becker JB et al. Exp Neurol 134, 244-252 (1995).
65. Guyot M-C, Hantraye P, Dolan R et al. Neuroscience 79, 45-56 (1997).
66. Koutouzis TK, Borlongan CV, Freeman TB et al. NeuroReport 5, 2241-2245 (1994).
67. Bossi SR, Simpson JR and Isacson O. NeuroReport 4, 73-76 (1993).
68. Browne SE, Bowling AC, MacGarvey U et al. Ann Neurol 41, 646-653 (1997).
69. Pei G and Ebendal T. Exp Neurol 132, 105-115 (1995).
70. Connop BP, Boegman RJ, Beninger RJ et al. Neuropharmacol 35, 459-465 (1996).
71. Connop BP, Boegman RJ, Beninger RJ et al. J Neurochem 68, 1191-1199 (1997).
72. Frim DM, Simpson J, Uhler TA et al. J Neurosci Res 35, 452-458 (1993).